AB vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

AB

50.9
AI Score
VS
AB Wins

IVZ

41.5
AI Score

Investment Advisor Scores

AB

51score
Recommendation
BUY

IVZ

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AB IVZ Winner
Forward P/E 10.5708 11.6686 AB
PEG Ratio 0.6343 0.9008 AB
Revenue Growth -40.3% 20.5% IVZ
Earnings Growth 20.9% 35.0% IVZ
Tradestie Score 50.9/100 41.5/100 AB
Profit Margin 390.6% -0.9% AB
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD AB

Relative Price Performance (Last 90 Days)

AB 1M: -2.4% · 3M: -5.0% IVZ 1M: +7.4% · 3M: +18.7%

Current Technical Phase

AB

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -0.8%) with fading momentum, RSI 41

RSI (14): 41.4 · Price: $36.26

IVZ

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 59

RSI (14): 58.8 · Price: $32.02

Fundamentals Snapshot

Metric AB IVZ
Market Cap
Forward P/E 9.4 9.8
Trailing P/E 10.8
Revenue (TTM)
Revenue Growth -0.4% 0.2%
Gross Margin 1.0% 0.3%
Operating Margin 1.0% 0.2%
EPS 3.33 -0.66
Dividend Yield 0.10% 0.03%

Frequently Asked Questions

Based on our detailed analysis, AB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.